Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN951007 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Calpain 3 (CAPN3) (AA 610-640), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Saturated Ammonium Sulfate (SAS) precipitation
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 610-640, C-Term
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions.
Immunohistochemical analysis of calpain 3: advantages and limitations in diagnosing LGMD2A.
Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance.
Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.
Moretti D, Del Bello B, Cosci E, Biagioli M, Miracco C, Maellaro E
Carcinogenesis 2009 Jun;30(6):960-7
Carcinogenesis 2009 Jun;30(6):960-7
Immunohistochemical analysis of calpain 3: advantages and limitations in diagnosing LGMD2A.
Charlton R, Henderson M, Richards J, Hudson J, Straub V, Bushby K, Barresi R
Neuromuscular disorders : NMD 2009 Jul;19(7):449-57
Neuromuscular disorders : NMD 2009 Jul;19(7):449-57
Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance.
Beckmann JS, Spencer M
Neuromuscular disorders : NMD 2008 Dec;18(12):913-21
Neuromuscular disorders : NMD 2008 Dec;18(12):913-21
Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.
Enjuanes A, Benavente Y, Bosch F, Martín-Guerrero I, Colomer D, Pérez-Alvarez S, Reina O, Ardanaz MT, Jares P, García-Orad A, Pujana MA, Montserrat E, de Sanjosé S, Campo E
Cancer research 2008 Dec 15;68(24):10178-86
Cancer research 2008 Dec 15;68(24):10178-86
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS